Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
PMID: 19106640
This was the first randomized, prospective cardiovascular outcomes trial to show that tirzepatide delivers cardiovascular benefits that extend beyond glycemic control and weight reduction in a highrisk secondaryprevention population
In the SOUL randomized clinical trial on oral semaglutide, for example, all participants taking semaglutide experienced clinically significant drops in blood pressure
& Abu-Farha, M
Efficacy was measured by monitoring changes in glycated hemoglobin (HbA1c) and body weight at week 12
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
.jpg)
